These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21778685)

  • 1. Does an inflammatory pattern at primary biopsy suggest a lower risk for prostate cancer at repeated saturation prostate biopsy?
    Pepe P; Aragona F
    Urol Int; 2011; 87(2):171-4. PubMed ID: 21778685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCA3 score vs PSA free/total accuracy in prostate cancer diagnosis at repeat saturation biopsy.
    Pepe P; Aragona F
    Anticancer Res; 2011 Dec; 31(12):4445-9. PubMed ID: 22199313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation.
    Pepe P; Aragona F
    Urology; 2007 Dec; 70(6):1131-5. PubMed ID: 18158033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is quantitative histologic examination useful to predict nonorgan-confined prostate cancer when saturation biopsy is performed?
    Pepe P; Fraggetta F; Galia A; Grasso G; Piccolo S; Aragona F
    Urology; 2008 Dec; 72(6):1198-202. PubMed ID: 19041023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential benefit of transrectal saturation prostate biopsy as an initial biopsy strategy: decreased likelihood of finding significant cancer on future biopsy.
    Li YH; Elshafei A; Li J; Hatem A; Zippe CD; Fareed K; Jones JS
    Urology; 2014 Apr; 83(4):714-8. PubMed ID: 24680442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saturation technique does not decrease cancer detection during followup after initial prostate biopsy.
    Lane BR; Zippe CD; Abouassaly R; Schoenfield L; Magi-Galluzzi C; Jones JS
    J Urol; 2008 May; 179(5):1746-50; discussion 1750. PubMed ID: 18343412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
    Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
    BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer detection by TURP after repeated negative saturation biopsy in patients with persistent suspicion of cancer: a case-control study on 75 consecutive patients.
    Pepe P; Fraggetta F; Galia A; Grasso G; Aragona F
    Prostate Cancer Prostatic Dis; 2010 Mar; 13(1):83-6. PubMed ID: 19901959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is a single focus of low-grade prostate cancer diagnosed on saturation biopsy predictive of clinically insignificant cancer?
    Pepe P; Fraggetta F; Galia A; Candiano G; Grasso G; Aragona F
    Urol Int; 2010; 84(4):440-4. PubMed ID: 20234121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PCA3 score accuracy in diagnosing prostate cancer at repeat biopsy: our experience in 177 patients.
    Barbera M; Pepe P; Paola Q; Aragona F
    Arch Ital Urol Androl; 2012 Dec; 84(4):227-9. PubMed ID: 23427750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lowering the PSA threshold for prostate biopsy from 4 to 2.5 ng/ml: influence on cancer characteristics and number of men needed to biopt.
    Müntener M; Kunz U; Eichler K; Puhan M; Schmid DM; Sulser T; Strebel RT
    Urol Int; 2010; 84(2):141-6. PubMed ID: 20215816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.
    Guazzoni G; Nava L; Lazzeri M; Scattoni V; Lughezzani G; Maccagnano C; Dorigatti F; Ceriotti F; Pontillo M; Bini V; Freschi M; Montorsi F; Rigatti P
    Eur Urol; 2011 Aug; 60(2):214-22. PubMed ID: 21482022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of insignificant prostate cancer using free/total PSA: results of a case-finding protocol on 14,453 patients.
    Pepe P; Aragona F
    Prostate Cancer Prostatic Dis; 2010 Dec; 13(4):316-9. PubMed ID: 20714341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PCA3 score and prostate cancer diagnosis at repeated saturation biopsy. Which cut-off: 20 or 35?
    Pepe P; Fraggetta F; Galia A; Skonieczny G; Aragona F
    Int Braz J Urol; 2012; 38(4):489-95. PubMed ID: 22951161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of prostate cancer after diagnosis of atypical glands suspicious for carcinoma on saturation and traditional biopsies.
    Abouassaly R; Tan N; Moussa A; Jones JS
    J Urol; 2008 Sep; 180(3):911-4; discussion 914. PubMed ID: 18635220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies.
    Stewart CS; Leibovich BC; Weaver AL; Lieber MM
    J Urol; 2001 Jul; 166(1):86-91; discussion 91-2. PubMed ID: 11435830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saturation technique does not improve cancer detection as an initial prostate biopsy strategy.
    Jones JS; Patel A; Schoenfield L; Rabets JC; Zippe CD; Magi-Galluzzi C
    J Urol; 2006 Feb; 175(2):485-8. PubMed ID: 16406977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidental acute prostatic inflammation is associated with a lower percentage of free prostate-specific antigen than other benign conditions of the prostate: a prospective screening study.
    Rowe EW; Laniado ME; Walker MM; Anup P
    BJU Int; 2006 May; 97(5):1039-42. PubMed ID: 16643488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of NIH-IV prostatitis on free and free-to-total PSA.
    Stancik I; Lüftenegger W; Klimpfinger M; Müller MM; Hoeltl W
    Eur Urol; 2004 Dec; 46(6):760-4. PubMed ID: 15548444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is race a positive predictor of cancer on repeat prostate biopsy?
    Yanke BV; Salzhauer EW; Colon I
    J Urol; 2006 Sep; 176(3):1114-7. PubMed ID: 16890704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.